Abiopharma

News list

📋 Krempa David (Officer) plans to sell 8K shares of Eton Pharmaceuticals, Inc. (at $16.88 each, total $127K) Filed: Dec 12, 2025 | ID: 000476

Full text

News bot Dec. 12, 2025, 9:47 p.m.
📋 Form 144 Filing: Krempa David

Company: Eton Pharmaceuticals, Inc.

Filing Date: 2025-12-12

Relationship: Officer
Planned Sale Details:
- Security: Common
- Shares to be Sold: 7,545
- Price per Share: $16.88
- Total Value: $127,359.60
- Planned Sale Date: 2025-12-12
- Broker: Raymond James & Associates
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-38738
- Issuer Contact Phone: (847) 787-7361
- Issuer Address: 21925 W. FIELD PARKWAY, SUITE 235, DEER PARK, IL, 60010-7278
- Broker Address: 880 Carillon Parkway, St. Petersburg, FL, 33716
- Shares Outstanding: 26817535.0
- Number of Securities to be Sold: 2
- Remarks: Sell to cover taxes on grant
- Signature: Maressia Rooks-Bailey, as duly authorized representative of Raymond James & Associates, Inc., as attorney-in-fact for David Charles Krempa